Pioneering Brain Cancer Technique Could Lead to Better Prognosis for Patients
4,000th paper published from Diamond research could improve outcomes for brain cancer sufferers
4,000th paper published from Diamond research could improve outcomes for brain cancer sufferers
Renowned gene therapy research team from the UCL Cancer Institute awarded a CytoFLEX Flow Cytometer
Which product made the most difference to drug discovery research in 2015?
New data paves way for adoption of sTNFR1 as a routine test for Diabetic Nephropathy management
The next generation CESI-MS system extends capabilities for biopharmaceutical, proteomics and metabolomics researchers
Which new product made the most difference to your laboratory in 2015?
Universal test designed for non-small cell lung cancer supports multiple drug development programs
Presents data on factors that affect the sensitivity of ADCC assays and discusses how to optimize methodology
Thermo Fisher Scientific showcases clinical research innovations at AMP 2015
Research is helping identify biomarkers of Alzheimer’s Disease
Comparative study of tumor biopsy v noninvasive blood-based analyses published
Booth 1415
KEYTRUDA is Merck's anti-PD-1 therapy for metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies
Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting